Is NAD+ a Peptide? No — It Is a Coenzyme. What NAD+, NMN and NR Actually Are and What the Evidence Shows

The short answer

NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a coenzyme built from two nucleotides — one carrying nicotinamide, one carrying adenine — joined through their phosphate groups. It has a mass of about 663 Da and contains no amino acids. It is present in every living cell, where it shuttles electrons in metabolism and serves as a substrate for sirtuins, PARP enzymes and CD38. It appears in peptide catalogues and “peptide clinic” menus because it is sold the same way — as a lyophilised vial for injection or an IV infusion — not because of anything about its chemistry.

NAD+, NMN and NR: the three names people mix up

NAD+ itself is the coenzyme. Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are precursors: molecules the body converts into NAD+ through the salvage pathway. Oral NAD+ is largely broken down in the gut, which is why the supplement market sells the precursors instead, and why clinics sell NAD+ by IV or subcutaneous injection to bypass digestion. Whether injected NAD+ enters cells intact, or is first degraded to precursors and rebuilt, is an open question in the literature.

The three molecules
	NAD+	NMN	NR
What it is	The coenzyme	Precursor (mononucleotide)	Precursor (riboside)
Mass	≈ 663 Da	≈ 334 Da	≈ 255 Da
Usual route sold	IV / injection	Oral capsule	Oral capsule
Human trials	Very few, small	Several small RCTs	Several small RCTs
Is it a peptide?	No	No	No

Why NAD+ interests researchers

Cellular NAD+ levels fall with age in several tissues, and restoring them extends healthspan in some mouse models — the basis of a large preclinical literature on sirtuins, mitochondrial function and DNA repair. That work is real and is why the precursors have been studied in humans. It is also why NAD+ is marketed alongside mitochondrial peptides such as MOTS-c and SS-31, which act on related pathways by entirely different mechanisms. The gap between the mouse data and any demonstrated human benefit is the point this page exists to make.

What human trials have shown

Oral NR and NMN reliably raise blood NAD+ levels in randomised trials, at doses of a few hundred milligrams to a gram a day, and are generally well tolerated over weeks to months. Clinical endpoints are far thinner: some trials report small improvements in insulin sensitivity, walking speed or blood pressure in specific groups, others report nothing, and none has shown an effect on ageing itself. For IV or injected NAD+, controlled human data are scarce — a handful of small studies, mostly in addiction and fatigue settings, without the design needed to draw conclusions. Claims of energy, cognition or longevity benefits from NAD+ injections rest on mechanism and testimonials, not trials.

Regulatory status

NR is sold as a dietary supplement in the US with a notified new-dietary-ingredient status. NMN's status shifted: the FDA said in 2022 that it was excluded from the supplement definition because it had been studied as a drug, then in 2025 reversed that position, allowing it back. NAD+ for injection is not an approved drug for any indication in the US, Canada or the EU; compounding pharmacies prepare it under compounding rules, and clinics administer it outside any approved labelling. None of the three is a controlled substance.

What this page is not

It corrects a classification — NAD+ is a coenzyme, not a peptide — and summarises the evidence for the coenzyme and its precursors. It does not recommend any of them, does not address doses or routes, and is not medical advice.

Sources and what they cover

These primary studies, official records and standards cover the topics linked below. The scope notes distinguish laboratory findings, human trials and regulatory records. This is a selected bibliography, not a systematic review or verification of every sentence; absence of a study here does not prove that no study exists.

FAQ

Is NAD+ a peptide?+

No. NAD+ is a dinucleotide coenzyme (about 663 Da) made of nicotinamide, adenine, two ribose sugars and two phosphates. It contains no amino acids.

What is the difference between NAD+, NMN and NR?+

NAD+ is the coenzyme itself; NMN and NR are precursors the body converts into NAD+. Oral NAD+ is poorly absorbed, so precursors are sold by mouth and NAD+ by injection.

Does NAD+ injection work?+

Controlled human trials of injected NAD+ are few and small. Oral precursors raise blood NAD+ reliably; clinical benefits beyond that remain unproven.

Is NAD+ approved?+

Not as a drug for any indication. NR is a dietary supplement; NMN's supplement status in the US was restored in 2025.

Why is NAD+ sold with peptides?+

Because it is sold in the same form — lyophilised vials and IV infusions — through the same channels, and marketed for overlapping goals. The chemistry is unrelated.